Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Monoclonal Antibody (MAb) | - | - | - | - | [1] 271 271 |
| 2 | Monoclonal antibody (Mab) sB24M | - | - | - | - | [1] 269 269 |
| 3 | Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically binds human IL-13, blocking interactions with the IL-13 receptor | [1] Tralokinumab Tralokinumab | [1] D09979
D09979
| [1] IL13 IL13 💬 | [8] Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [1] 85 85 |